Back

Cardiovascular outcomes in diabetic patients treated with SGLT2i and GLP1-RA: systematic review and meta-analysis

19 May 2025 (09:45 - 10:07)
Organised by: Logo
Congress Presentation Part of: Risk prediction and treatment: bring your crystal ball? Diabetes and the Heart HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Gaetano Marino

San Filippo Neri Hospital, Rome (Italy)

1 More presentation in this session

Presentation thumbnail
Ring-like late gadolinium enhancement: exploring patterns and outcomes
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk prediction and treatment: bring your crystal ball?
Video

The Event

Event poster

Heart Failure 2025

19 May 2025 09:45 CET
You may be interested in
thumbnail
Congress Session
Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?
thumbnail
Congress Session
What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?
thumbnail
Congress Presentation
Exploring the risk of ventricular arrhythmia and sudden cardiac death with SGLT2 inhibitors in heart failure patients: a comprehensive systematic review and bayesian network meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources